期刊文献+

抗牙龈卟啉单胞菌血凝素2单克隆抗体的制备 被引量:4

Preparation of anti-HA2 monoclonal antibody
原文传递
导出
摘要 目的制备抗牙龈卟啉单胞菌(Porphyromonas gingivalis,Pg)血凝素2(hemagglutinin-2,HA-2)的单克隆抗体(monoclonal antibody,mAb)。方法用重组HA-2(recombinant HA-2,rHA-2)免疫BALB/C小鼠,取其脾细胞与小鼠骨髓瘤细胞SP2/0融合,间接ELISA方法筛选杂交瘤细胞.用ELISA方法测效价。结果获得1株能够高效识别rHA-2的mAb,命名为4F11。此单克隆抗体的免疫球蛋白亚类为IgG1,效价达1?106。结论成功制备了重组牙龈卟啉单胞菌血凝素2的单克隆抗体mAb.将进一步用于牙龈卟啉单胞菌的诊断,并为牙周疾病的治疗研究奠定基础。 Objective To prepare monoclonal antibody against recombinant hemagglutinin(rHA-2) of Porphyromonas gingivalis(Pg).Method Hybridomas were generated by the fusion of Sp2/0 myelomas and spleen cells,which were obtained from mice immunized with rHA-2.The hybirdoma cell lines were selected by enzyme linked immunosorbent assay(ELISA).The titer of mAb was identified by ELISA methods.Result One hybridoma cell line stably secreting anti-HA-2 mAbs was produced,which was named 4F11.The isotype of the mAb was IgG1.And the titer of the anti-HA-2 m-Ab was detected as up to 1︰106 by ELISA.Conclusion The mAb against Pg rHA-2 was successfully prepared,which will be useful for the detection of Pg infection and provides a foundation for the development of therapy of periodontal disease.
出处 《中国微生态学杂志》 CAS CSCD 2011年第4期332-334,共3页 Chinese Journal of Microecology
关键词 单克隆抗体 牙龈卟啉单胞菌 血凝素 Monoclonal antibody Porphyromonas gingivalis Hemagglutinin
  • 相关文献

参考文献7

  • 1DECARLO A A,PARAMAESVARAN M,YUN P L W. Porphyrin-me- diated binding to hemoglobin by the HA2 domain of cysteine proteina- ses (gingipains) and hemagglutinins from the periodontal pathogen Porphyromonas gingivalis [ J ]. J B acteriol, 1999,181 ( 12 ) : 3784 -3791.
  • 2NGUYEN K A, DeCARLO A A, PARAMAESVARAN M. Humoral responses to Porphyronwnas gingivalis gingipain adhesin domains in sub- jects with chronic periodonfitis[ J ]. Infect lmmun ,2004,72 ( 3 ) : 1374- 1382.
  • 3杨秋波,余飞燕,杨圣辉.牙龈卟啉单胞菌血凝素2与氯化血红素结合多肽的序列分析[J].中华口腔医学杂志,2009,44(9):538-542. 被引量:5
  • 4余飞燕,杨秋波,杨圣辉.多肽内切酶鉴定牙龈卟啉单胞菌血凝素2结合位点[J].中国微生态学杂志,2010,22(5):452-454. 被引量:5
  • 5DeCARLO A A, HUANG Y, COLLYER C. Feasibility of an HA2 do main-based periodontitis vaccine[ J]. Infect Immun ,2003,71 ( 1 ) :562- 566.
  • 6DeCARLO A A, NADKARNI M, PARAMAESVARAN M. Serum anti- bodies against the hemoglobin-binding domain (HA2) of Porphyromonas gingivalis [ J ]. J Periodontal Res. 2004.39 ( 4 ) :228-235.
  • 7Van TILBURG M L, KOZAROV E V, PROGULSKE-FOX A,et al. The effect of monoclonal antibody and route of immunization on the humoral immune response against Porphyromonas gingivalis[ J ]. Oral Microbiol Immuno1,2001,16 ( 3 ) : 153-162.

二级参考文献19

  • 1Fujimura S, Shibata Y, Hirai K, et al. Binding of hemoglobin to the envelope of porphyromonas gingivalis and isolation of the hemoglobin-binding protein. Infect Immun, 1996,64 (6) : 2339- 2342.
  • 2Nakayama K, Ratnayake DB, Tsukuba T, et al. Haemoglobin receptor protein is intragenically encoded by the cysteine proteinase-encoding genes and the haemagglutinin-encoding gene of Porphyromonas ging/valis. Mol Microbiol, 1998, 27 ( 1 ) : 51-61.
  • 3Pavloff N, Potempa J, Pike RN, et al. Molecular cloning and structural characterization of the Arg-gingipain proteinase of Porphyromonas gingivalis. Biosynthesis as a proteinase-adhesin polyprotein. J Biol Chem, 1995, 270(3) : 1007-1010.
  • 4DeCarlo AA, Paramaesvaran M, Yun PL, et al. Porphyrin-mediated binding to hemoglobin by the HA2 domain of cysteine proteinases (gingipains) and hemagglutinins from the periodontal pathogen Porphyromonas gingivalis. J Bacteriol, 1999, 181 (12) : 3784-3791.
  • 5Nguyen KA, DeCarlo AA, Paramaesvaran M, et al. Humoral responses to Porphyromonas gingivalis gingipain adhesin domains in subjects with chronic periodontitis. Infect Immun, 2004,72(3) :1374-1382.
  • 6DeCarlo AA, Nadkarni M, Paramaesvaran M, et al. Serum antibodies against the hemoglobin-binding domain (HA2) of Porphyromonas gingivalis. J Periodontal Res, 2004, 39 (4) :228- 235.
  • 7Paramaesvaran M, Nguyen KA, Caldon E, et al. Porphyrinmediated cell surface heme capture from hemoglobin by Porphyromonas gingivalis. J Bacteriol, 2003, 185 ( 8 ) : 2528- 2537.
  • 8Yap BC, Simpkins GL, Collyer CA. Porphyrin-linked nitroimidazole antibiotics targeting Porphyromonas gingivalis. Org Biomol Chem, 2009, 21 (14):2855-2863.
  • 9Decarlo AA, Huang Y, Collyer C, et al. Feasibility of an HA2 domain-based periodontitis vaccine. Infect Immun, 2003, 71 ( 1 ) : 562-566.
  • 10Katz J, Chegini N, Shiverick KT, et al. Localization of P. gingivalis in preterm delivery placenta J Dent Res, 2009, 88 (6) :575-578.

共引文献5

同被引文献28

  • 1阮萍,罗耀东,严杰.牙龈卟啉单胞菌prtC基因原核表达系统构建及牙周损伤与局部 PrtC水平的关系(英文)[J].中国人兽共患病杂志,2005,21(5):369-374. 被引量:2
  • 2Yan-min WU,Li-li CHEN,Jie YAN,Chun-yan ZHUANG,Zhi-yuan GU.Effect of Porphyromonas gingivalis PrtC on cytokine expression in ECV304 endothelial cells and its level in subgingival plaques from patients with chronic periodontitis[J].Acta Pharmacologica Sinica,2007,28(7):1015-1023. 被引量:4
  • 3SMALLEY J W, BIRSS A J, SZMIGIELSKI B, et al. The HA2 haemag- glutinin domain of the lysine-specific gingipain ( Kgp ) of Porphy- romonas gingivalis promotes micro-oxo bishaem formation from mono- meric iron (Ⅲ ) protoporphyrin Ⅸ [ J ]. Microbiology,2006,152 ( pt6 ) : 1839-1845.
  • 4DECARLO A A,PARAMAESVARAN M, YUN P L W. Porphyrin-me- diated binding to hemoglobin by the HA2 domain of cysteine proteina- ses (gingipains) and hemagglutinins from the periodontal pathogen Porphymmonas gingiavalis [ J ]. J Bacteriol, 1999, 181 ( 12 ) : 3784- 3791.
  • 5~NGUYEN K A,DECARLO A A,PARAMAESVARAN M. Humoral re- sponses to Porphyromonas girtgivalis gingipain adhesin domains in sub- jects with chronic periodontitis [ J ]. Infect Immun, 2004,72 ( 3 ) : 1374- 1382.
  • 6DECARLO A A, NADKARNI M, PARAMAESVARAN M. Serum anti- bodies against the hemoglobin-binding domain (HA2) of Porphy- romonas gingivalis [ J ]. Periodontal Res,2004,39 (4) :228-235.
  • 7Smalley JW,Birss A J,Szmigielski B,et al.The HA2 haemaggluti-nin domain of the lysine-specific gingipain(Kgp)of Porphyromonas gingivalis promotes micro-oxo hishaem formation from monomeric i-ron(Ⅲ)protoporphyrin Ⅸ [J].Microbiology,2006,152(pt6):1839-1845.
  • 8Pinto LA,Berzofsky JA,Fowde KR,et al.HIV-specifie immunity following immunization with HIV synthetic envope peptides in a-symptomatic HIV-infect patients [J].AIDS,1999,13(15):2003-2012.
  • 9Atzpodien J,Reitz M.GM-CSF plus antizenic peptide vaeeination in locally advanced melanoma patients [J].Cancer Biother Radiop-harm,2007,22(4):551-555.
  • 10Cathcart K,Pinilla-lbarz J,Korontsvit T,et al.A multivalent bcr-abl fusinn peptide vaccination trial in patients with chronic mye-loid leukemia[J].Blood,2004,103(3):1037-1042.

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部